Evidence map›Paper›PMID 22303491›Full record

ArticlePLoS neglected tropical diseases2012

High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata.

Kathryn E Holt, Shanta Dutta, Byomkesh Manna, Sujit K Bhattacharya, Barnali Bhaduri, Derek J Pickard, R Leon Ochiai, Mohammad Ali, John D Clemens, Gordon Dougan

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Kathryn E HoltDepartment of Microbiology and Immunology, University of Melbourne, Melbourne, Australia. kholt@unimelb.edu.au
Shanta Dutta
Byomkesh Manna
Sujit K Bhattacharya
Barnali Bhaduri
Derek J Pickard
R Leon Ochiai
Mohammad Ali
John D Clemens
Gordon Dougan
National Institute of Cholera and Enteric Diseases · INInternational Vaccine Institute · KRWellcome Sanger Institute · GBUniversity of Melbourne · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundTyphoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), is a major health problem especially in developing countries. Vaccines against typhoid are commonly used by travelers but less so by residents of endemic areas. METHODOLOGY: We used single nucleotide polymorphism (SNP) typing to investigate the population structure of 372 S. Typhi isolated during a typhoid disease burden study and Vi vaccine trial in Kolkata, India. Approximately sixty thousand people were enrolled for fever surveillance for 19 months prior to, and 24 months following, Vi vaccination of one third of the study population (May 2003-December 2006, vaccinations given December 2004). PRINCIPAL

findingsA diverse S. Typhi population was detected, including 21 haplotypes. The most common were of the H58 haplogroup (69%), which included all multidrug resistant isolates (defined as resistance to chloramphenicol, ampicillin and co-trimoxazole). Quinolone resistance was particularly high among H58-G isolates (97% Nalidixic acid resistant, 30% with reduced susceptibility to ciprofloxacin). Multiple typhoid fever episodes were detected in 22 households, however household clustering was not associated with specific S. Typhi haplotypes.

conclusionsTyphoid fever in Kolkata is caused by a diverse population of S. Typhi, however H58 haplotypes dominate and are associated with multidrug and quinolone resistance. Vi vaccination did not obviously impact on the haplotype population structure of the S. Typhi circulating during the study period.

Indexed as

Disease OutbreaksMolecular TypingAnti-Bacterial AgentsClinical Trials as TopicDrug Resistance, BacterialGenotypeHumansIndiaMolecular EpidemiologyPolymorphism, Single NucleotideQuinolonesSalmonella typhiTyphoid FeverTyphoid-Paratyphoid VaccinesVaccinationAnti-Bacterial AgentsQuinolonesTyphoid-Paratyphoid Vaccines

Identifiers

PMID22303491
PMCPMC3269425
OpenAlexW2050688784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.